These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [An important variability factor in determination of urinary activity of N-acetyl-beta-D-glucosaminidase: contamination of urine with semen]. Pastoris A; Artioli D; Catalani S; Alinovi R; Sbaffi A; Mutti A; Apostoli P Med Lav; 2004; 95(3):180-5. PubMed ID: 15293374 [TBL] [Abstract][Full Text] [Related]
4. [Urinary enzymes as markers of functional state of kidneys with diabetic lesions]. Myhal' LIa; Korol' LV; Nikulina HH; Dudar IO; Zheltovs'ka NV Fiziol Zh (1994); 2006; 52(1):89-93. PubMed ID: 16553303 [TBL] [Abstract][Full Text] [Related]
5. [Studies of enzymuria and proteinuria: Report 1: N-acetyl-beta-glucosaminidase in urological diseases]. Yasumoto R; Asakawa M; Yamamoto M; Doi Y; Kakinoki K; Kawashima H; Yoshimura R; Umeda M; Maekawa T Hinyokika Kiyo; 1987 Jun; 33(6):807-11. PubMed ID: 2445186 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of urinary and seminal N-acetyl-beta-glucosaminidase isoenzymes]. Yasumoto R; Asakawa M; Yamamoto M; Doi Y; Kawashima H; Umeda M; Tanabe S; Nishisaka N; Kakinoki K; Maekawa M Hinyokika Kiyo; 1987 Nov; 33(11):1827-9. PubMed ID: 3445866 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme activities in the urine of children with primary and secondary hypertension]. Zoch-Zwierz W; Winiecka W; Tomaszewska B; Wierciński R Wiad Lek; 1992 Jul; 45(13-14):498-502. PubMed ID: 1462566 [TBL] [Abstract][Full Text] [Related]
8. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model]. Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687 [TBL] [Abstract][Full Text] [Related]
9. Expression modes of urinary N-acetyl-beta-D-glucosaminidase in patients with chronic renal insufficiency. Tassi C; Mancuso F; Feligioni L; Marangi M; Capodicasa E Clin Chim Acta; 2004 Aug; 346(2):129-33. PubMed ID: 15256313 [TBL] [Abstract][Full Text] [Related]
10. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus. Piwowar A; Knapik-Kordecka M; Fus I; Warwas M Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878 [TBL] [Abstract][Full Text] [Related]
11. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)]. Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703 [TBL] [Abstract][Full Text] [Related]
12. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Price RG Clin Nephrol; 1992; 38 Suppl 1():S14-9. PubMed ID: 1295704 [TBL] [Abstract][Full Text] [Related]
13. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead]. Milnerowicz H; Bizoń A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537 [TBL] [Abstract][Full Text] [Related]
14. The possibility of determining N-acetyl-beta-D-glucosaminidase isoenzymes under alkaline conditions. Mandić LM; Aćimović JM; Jovanović VB Clin Biochem; 2005 Apr; 38(4):384-9. PubMed ID: 15766740 [TBL] [Abstract][Full Text] [Related]
15. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy. Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599 [TBL] [Abstract][Full Text] [Related]
16. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas. Moriguchi J; Inoue Y; Kamiyama S; Horiguchi M; Murata K; Sakuragi S; Fukui Y; Ohashi F; Ikeda M Toxicol Lett; 2009 Oct; 190(1):1-8. PubMed ID: 19467302 [TBL] [Abstract][Full Text] [Related]
17. Stabilities of N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes in urine: advantage of NAG isoenzyme B measurement in clinical applications. Morita A; Numata Y; Kosugi Y; Noto A; Takeuchi N; Uchida K Clin Chim Acta; 1998 Nov; 278(1):35-43. PubMed ID: 9877122 [TBL] [Abstract][Full Text] [Related]
18. Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine methods and clinical applications. Price RG Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):693-705. PubMed ID: 1493161 [TBL] [Abstract][Full Text] [Related]
19. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function]. Skrezek C; Bertermann H; Schulz FP; König B Urologe A; 1990 Jan; 29(1):27-31. PubMed ID: 2316078 [TBL] [Abstract][Full Text] [Related]
20. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]